HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK’s EM Pharma Expands OTC Portfolio With Natural Anti-Viral Nasal Spray

Executive Summary

Brits worried about contracting cold and flu viruses can now turn to EM Pharma's natural Nasofed nasal spray, which the firm says may also fight novel coronaviruses like COVID-19.

You may also be interested in...



EU Business News: Perrigo Adds Protective Nasal Spray, HRA Partners With Hermes

The latest European consumer health business news: Perrigo has struck a deal to market Marinomed's protective nasal spray in selected countries; and HRA Pharma has teamed up with Hermes in Germany and Austria to enhance its offering to pharmacy.

Herbal Sprays, Nasal Swabs Latest Additions On List Of Fraudulent COVID Cures Offered In US

“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”

Starpharma Pauses UK Sales Of COVID Nasal Spray

Starphama has paused sales of its antiviral COVID-19 nasal spray following correspondence with the UK medicines regulator in relation to specific promotional claims made for Viraleze, including references to SARS-CoV-2 and COVID-19, and the interrelationship between these product claims and its categorization,” according to the firm.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel